Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
Go back to Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer| (NASDAQ: CADL) | Delayed: 10.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.68 | 52 Week High | $ | |||
| Open | $10.68 | 52 Week Low | $ | |||
| Day High | $10.68 | P/E | N/A | |||
| Day Low | $10.68 | EPS | $ | |||
| Volume | 1 | |||||

